Wolfgang Schönhofer

Title: Wolfgang Schönhofer: Innovator in Biopharmaceutical Purification

Introduction

Wolfgang Schönhofer is a notable inventor based in St. Pölten, Austria. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of critical proteins. With a total of 2 patents to his name, Schönhofer's work has the potential to impact medical treatments significantly.

Latest Patents

One of Schönhofer's latest patents is a method for the purification of antithrombin III using an anion exchanger. This innovative method involves adsorbing the AT III/heparin complex or the AT III/heparinoid complex on an anion exchanger material. Following this, the method separates the AT III from the adsorbed complex by elution with a buffer that has a pH ranging from 8.5 to 10.5 and a conductivity between 10 and 60 mS. Another significant patent is for a highly purified factor VIII complex, which comprises the components factor VIII and vWF. This complex boasts a specific activity of at least 70, preferably between 100 to 300 U factor VIII:C/mg, and includes a stable pharmaceutical preparation containing this complex along with a method of producing it.

Career Highlights

Wolfgang Schönhofer is currently associated with Baxter Aktiengesellschaft, a leading global biopharmaceutical company. His work at Baxter focuses on developing innovative purification methods that enhance the efficacy and safety of biopharmaceutical products.

Collaborations

Throughout his career, Schönhofer has collaborated with esteemed colleagues, including Yendra Linnau and Johann J. Eibl. These collaborations have fostered an environment of innovation and have contributed to the advancement of biopharmaceutical technologies.

Conclusion

Wolfgang Schönhofer's contributions to the field of biopharmaceutical purification are noteworthy. His innovative methods and collaborations have the potential to enhance medical treatments and improve patient outcomes.